全文获取类型
收费全文 | 24949篇 |
免费 | 1807篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 276篇 |
儿科学 | 610篇 |
妇产科学 | 502篇 |
基础医学 | 3433篇 |
口腔科学 | 770篇 |
临床医学 | 2874篇 |
内科学 | 5001篇 |
皮肤病学 | 227篇 |
神经病学 | 2657篇 |
特种医学 | 1030篇 |
外国民族医学 | 2篇 |
外科学 | 3006篇 |
综合类 | 357篇 |
一般理论 | 24篇 |
预防医学 | 1959篇 |
眼科学 | 486篇 |
药学 | 2039篇 |
中国医学 | 20篇 |
肿瘤学 | 1568篇 |
出版年
2023年 | 99篇 |
2022年 | 152篇 |
2021年 | 377篇 |
2020年 | 244篇 |
2019年 | 337篇 |
2018年 | 383篇 |
2017年 | 354篇 |
2016年 | 410篇 |
2015年 | 508篇 |
2014年 | 708篇 |
2013年 | 1064篇 |
2012年 | 1603篇 |
2011年 | 1736篇 |
2010年 | 1050篇 |
2009年 | 901篇 |
2008年 | 1671篇 |
2007年 | 1619篇 |
2006年 | 1615篇 |
2005年 | 1712篇 |
2004年 | 1562篇 |
2003年 | 1536篇 |
2002年 | 1440篇 |
2001年 | 296篇 |
2000年 | 227篇 |
1999年 | 317篇 |
1998年 | 400篇 |
1997年 | 314篇 |
1996年 | 301篇 |
1995年 | 281篇 |
1994年 | 226篇 |
1993年 | 199篇 |
1992年 | 174篇 |
1991年 | 156篇 |
1990年 | 144篇 |
1989年 | 156篇 |
1988年 | 153篇 |
1987年 | 146篇 |
1986年 | 149篇 |
1985年 | 152篇 |
1984年 | 163篇 |
1983年 | 160篇 |
1982年 | 205篇 |
1981年 | 174篇 |
1980年 | 189篇 |
1979年 | 100篇 |
1978年 | 120篇 |
1977年 | 115篇 |
1976年 | 89篇 |
1975年 | 89篇 |
1974年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
A Ascari-Raccagni†‡ MG Righini† 《Journal of the European Academy of Dermatology and Venereology》2006,20(5):514-516
BACKGROUND: Repairing dorsal nasal defects is a frequent challenge for dermatologic surgeons, mainly due to the high frequency of basal cell carcinomas on this site. Obvious scars, mismatched skin and distortion of the nasal contour are the surgical hazards that must be avoided in these cases. AIM: Our aim was to perform surgery involving a simple flap in order to repair medium to large defects on the dorsal side of the nose. METHODS: The dorsal horizontal advancement flap was studied in 12 patients, in order to evaluate the benefits and limits of this surgical procedure. RESULTS: The resulting scars on most of our patients were well-camouflaged among their natural skin lines, and there was neither distortion of the alar contour nor the nostril. CONCLUSIONS: This flap is easy to perform and, in selected cases, provides an outstanding alternative to second-intention healing, full-thickness skin grafts, transposition, rotation and pedicle flaps. 相似文献
4.
Roger F Uren 《Journal of nuclear medicine》2006,47(2):191-195
5.
We report on 4 children who experienced a syncopal episode while being treated with guanfacine without any other evident cause. Syncope appears to be an uncommon side effect of guanfacine and is probably due to drug-induced hypotension or bradycardia. 相似文献
6.
Marjorie Shaw Phillips Roger L Williams 《American journal of health-system pharmacy》2006,63(2):139-142
PURPOSE: Recommendations of the interdisciplinary Safe Medication Use Expert Committee of the United States Pharmacopeia (USP) to assist health care professionals, manufacturers, and organizations in handling neuromuscular blocking agents (NMBAs) safely and effectively are discussed. SUMMARY: Review and analysis of the USP Medication Errors Reporting Program and MEDMARX program databases showed a continuing risk of patient harm or death due to errors with NMBAs. Medication errors involving wrong concentrations, wrong doses, wrong drugs, look-alike packaging, and sound-alike names, combined with lack of monitoring and communication, have been associated with the use of NMBAs in health care institutions. Serious adverse events occur when NMBAs are used without adequate safeguards. Recommendations for improving safety were developed through review and discussion of root causes and areas of concern with these medications. CONCLUSION: Medical errors with NMBAs continue to result in patient morbidity and mortality. Increased awareness and action on the part of all parties involved are needed to improve the safety of this class of medications. 相似文献
7.
Juin Fok-Seang Linda C. Smith-Thomas Sally Meiners Elizabeth Muir Jian-Sheng Du Elizabeth Housden Alan R. Johnson Andreas Faissner Herbert M. Geller Roger J. Keynes John H. Rogers James W. Fawcett 《Brain research》1995,689(2):207
The adult mammalian central nervous system (CNS) lacks the capacity to support axonal regeneration. There is increasing evidence to suggest that astrocytes, the major glial population in the CNS, may possess both axon-growth promoting and axon-growth inhibitory properties and the latter may contribute to the poor regenerative capacity of the CNS. In order to examine the molecular differences between axon-growth permissive and axon-growth inhibitory astrocytes, a panel of astrocyte cell lines exhibiting a range of axon-growth promoting properties was generated and analysed. No clear correlation was found between the axon-growth promoting properties of these astrocyte cell lines with: (i) the expression of known neurite-outgrowth promoting molecules such as laminin, fibronectin andN-cadherin; (ii) the expression of known inhibitory molecules such tenascin and chondroitin sulphate proteoglycan; (iii) plasminogen activator and plasminogen activator inhibitor activity; and (iv) growth cone collapsing activity. EM studies on aggregates formed from astrocyte cell lines, however, revealed the presence of an abundance of extracellular matrix material associated with the more inhibitory astrocyte cell lines. When matrix deposited by astrocyte cell lines was assessed for axon-growth promoting activity, matrix from permissive lines was found to be a good substrate, whereas matrix from the inhibitory astrocyte lines was a poor substrate for neuritic growth. Our findings, taken together, suggest that the functional differences between the permissive and the inhibitory astrocyte cell lines reside largely with the ECM. 相似文献
8.
9.
10.
Michael Rosenzweig Martha Skinner Tatiana Prokaeva Roger Théberge Catherine Costello Brian M Drachman Lawreen H Connors 《Amyloid》2007,14(1):65-71
We report the identification of a new transthyretin (TTR) gene mutation and variant protein, Glu61Gly, in a 55-year-old man with progressive cardiomyopathy, mild peripheral neuropathy and bilateral carpal tunnel syndrome. A diagnosis of TTR-associated familial amyloidosis (ATTR) was considered after an endomyocardial biopsy revealed amyloid deposits in the heart of a patient who had no family history of amyloidosis and no evidence of a plasma cell dyscrasia. Serum screening for a TTR variant by isoelectric focusing (IEF) was positive and prompted further studies to identify the genetic abnormality and to characterize the amyloidogenic protein. Direct DNA sequence analysis of all four coding regions in the TTR gene demonstrated heterozygosity in exon 3. Near equal amounts of guanine (G) and adenine (A) were observed at the second base position of codon 61. The wild-type (GAG) and mutated (GGG) sequences found in codon 61 correspond to glutamic acid (Glu) and glycine (Gly) residues, amino acids which differ in mass by -72 Da. Mass spectrometric analyses of TTR immunoprecipitated from serum showed the presence of both wild-type and variant proteins. The observed mass results for the wild-type and variant proteins were consistent with the predicted values calculated from the genetic analysis data. 相似文献